ASPEN PHARMACR Balance Sheet - Annual (OTCMKTS:APNHY)

Add to My Stocks
$11.93 $0.21 (1.73%) APNHY stock closing price Sep 25, 2018 (Closing)

The financial analysis of a company like ASPEN PHARMACR involves checking the three financial statements of the company in detail, of which the balance sheet is one. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our ASPEN PHARMACR stock analysis. Annual results are typically accompanied with the company releasing financial statements. The balance sheet shows total liabilities of $5.38B and shareholders equity of $3.17B. ASPEN PHARMACR revenue and ASPEN PHARMACR operating cash flow are important in understanding the financial capacity of the company.

View latest 10 year balance sheet data to check ASPEN PHARMACR financial performance.
show more
Fiscal year is Jul - Jun20172016
Cash786.45M756.46M
Marketable Securities--
Receivables999.6M818.92M
Inventory999.6M999.36M
Raw Materials301.35M249.84M
Work In Progress345.45M367.82M
Finished Goods352.8M381.7M
Notes Receivable--
Other Current Assets14.7M6.94M
Total Current Assets
2.8B2.58B
Property Plant & Equipment1.01B909.14M
Accumulated Depreciation294M235.96M
Net Property Plant & Equipment
712.95M673.18M
Investment & Advances--
Other Non-Current Assets--
Deferred Charges73.5M76.34M
Intangibles4.84B3.82B
Deposits & Other Assets117.6M83.28M
Total Assets
8.55B7.24B
Notes Payable--
Accounts Payable757.05M576.02M
Current Portion Long-Term Debt1.39B756.46M
Current Portion Capital Leases--
Accrued Expenses--
Income Taxes Payable--
Other Current Liabilities411.6M131.86M
Total Current Liabilities
2.56B1.46B
Mortgages--
Deferred Taxes/Income154.35M124.92M
Convertible Debt--
Long-Term Debt2.12B2.27B
Non-Current Capital Leases--
Other Long-Term Liabilities543.9M430.28M
Total Liabilities
5.38B4.29B
Minority Interest--
Preferred Stock--
Common Stock Net139.65M131.86M
Capital Surplus--
Retained Earnings2.37B1.97B
Treasury Stock--
Other Liabilities654.15M846.68M
Shareholders Equity3.17B2.95B
Total Liabilities & Shareholders Equity8.55B7.24B
All figures in USD. M: Millions of USD, B: Billions of USD.

Most investors just check the ASPEN PHARMACR stock price, and ASPEN PHARMACR historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the ASPEN PHARMACR PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: Anything that the ASPEN PHARMACR company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. ASPEN PHARMACR had total assets of $8.55B.
  • Liabilities: This item on the balance sheet implies the firm's, in this case ASPEN PHARMACR's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for APNHY stock stand at $5.38B.

ASPEN PHARMACR Balance Sheet - Key Ratios